Drug Trial Radar · NCT05167864
Evaluation of Four Injectable Neuromodulators in the Glabella Area Glabella Area
Last checked: Nov 20, 2026Latest source record: Jan 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
143
Actual
Start
Mar 4, 2022
Primary completion
Jun 30, 2023
Study completion Jun 30, 2023
Sponsor
- Lead sponsor
- University of PennsylvaniaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 22, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, care provider)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 30 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to use 3D imaging to evaluate the effects of four FDA approved neuromodulators on facial lines, wrinkles and animation. Participation is available to women who have never had a cosmetic procedure above the malar region nor a treatment with a neuromodulator within 12 months. All subjects will undergo 3D imaging using the VECTRA M3 (Canfield Scientific, Inc, Fairfield, NJ) prior to treatment with a neuromodulator in order to determine their baseline dimensions. Imaging will be repeated post injection to determine change over time.
Conditions
- Cosmetic Techniques
Interventions
Onabotulinumtoxina for InjectionDrug
cosmetic injection into the glabella area (eyebrow area)
Abobotulinumtoxina for InjectionDrug
cosmetic injection into the glabella area (eyebrow area)
IncobotulinumtoxinA for InjectionDrug
cosmetic injection into the glabella area (eyebrow area)
PrabotulinumtoxinA for InjectionDrug
cosmetic injection into the glabella area (eyebrow area)
Primary outcomes
What the sponsor says the trial is designed to measure.
- the Change in Dynamic Strain in the Glabella Area After Injection Over TimeTime frame: day 3, day 30, day 90, day 180
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Penn Medicine
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.